How many FDA warning letters has Kico Knee Innovation Company received?

Argus HQ has not recorded an FDA warning letter for Kico Knee Innovation Company in our current dataset.

What FDA recalls has Kico Knee Innovation Company issued?

Argus HQ has recorded 2 FDA recalls tied to Kico Knee Innovation Company.

Is Kico Knee Innovation Company FDA compliant?

Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 2 recalls, and 0 approval records for Kico Knee Innovation Company. Review the linked FDA source records directly before drawing a compliance conclusion.

.hq

company

Kico Knee Innovation Company

Name: FDA Enforcement Actions Against Kico Knee Innovation Company
Creator: Argus HQ
License: https://argushq.ai/methodology

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

fda_recall · device_recall2026-06-10
Kico Knee Innovation Company — Class II recall: Arvis Hip & Knee 3.0 Instrument Set, REF: IN-28000 containing one of the followi…
fda_recall · device_recall2026-06-10
Kico Knee Innovation Company — Class II recall: Arvis Hip & Knee 2.0 Instrument Set, REF: IN-21200 containing one of the followi…

Frequently asked questions

How many FDA warning letters has Kico Knee Innovation Company received?: Argus HQ has not recorded an FDA warning letter for Kico Knee Innovation Company in our current dataset.
What FDA recalls has Kico Knee Innovation Company issued?: Argus HQ has recorded 2 FDA recalls tied to Kico Knee Innovation Company.
Is Kico Knee Innovation Company FDA compliant?: Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 2 recalls, and 0 approval records for Kico Knee Innovation Company. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.